60
insulin pen
Worth a lookShows a thin review moat (21 avg reviews), but a failed launch gate (market size, growth, or returns) keeps it on the watch list.
Review moat
Incredible20.77avg incumbent reviews — the moat a new listing must climb
Returns
Incredible0.8%return rate — above 5% kills the launch gate
Avg price
Incredible£25.46avg listing price — sweet spot $15–$100
Quality gap
Great4.2★avg incumbent rating — lower means beatable quality
Price range
Great£4.09–£51.95cheapest to priciest tracked listing — scored on the share inside $15–$100
Brand share
Great59%top-5 brand share — no brand owns this niche
Competition
Good49%top-5 click share — leaders hold, buyers still browse
Growth
Good+20.3%90-day search growth — must beat 0% to launch
Conversion
Okay2.1%search→purchase rate — share of searches ending in a sale
Market size
Bad£51K£51K/yr · 97K searches